✦ LIBER ✦

Polymorphous light eruption: A clinical, photobiologic, and follow-up study of 110 patients

✍ Scribed by Heleen E. Boonstra; Huib van Weelden; Johan Toonstra; Willem A. van Vloten

Book ID: 117393359
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 93 KB
Volume: 42
Category: Article
ISSN: 1097-6787
DOI: 10.1016/s0190-9622(00)90126-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antinuclear antibodies in patients with

Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study

✍ S. Tzaneva; B. Volc-Platzer; H. Kittler; H. Hönigsmann; A. Tanew 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Treatment of polymorphous light eruption

Treatment of polymorphous light eruption with nicotinamide: a pilot study

✍ R. NEUMANN; E. RAPPOLD; HELGA POHL-MARKL 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Pinpoint papular variant of polymorphous

Pinpoint papular variant of polymorphous light eruption: clinical and pathological correlation

✍ I Bansal; H Kerr; JJ Janiga; HS Qureshi; M Chaffins; HW Lim; A Ormsby 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Clinical subtypes and phototesting studi

Clinical subtypes and phototesting studies on 311 Chinese patients with polymorphous light eruption

✍ Liao, Kanghuang; Wang, Yi; Xia, Yuqing 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Clinical study and follow-up of 100 pati

Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome

✍ Francisco J. Muñoz-Rodríguez; Josep Font; Richard Cervera; Joan Carles Reverter; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 822 KB

Burkitt's lymphoma. A clinical study of

Burkitt's lymphoma. A clinical study of 110 patients

✍ F. K. Nkrumah; I. V. Perkins 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

O n e hundred and ten previously untreated patients with Burkitt's lymphoma were studied prospectively over a period ranging from over 1 year to 5 years. Of 103 patients who were treated with cyclophosphamide as a single agent, 79 (77%) achieved complete remission. Vincristine plus methotrexate o r